Do you want to read an article? Please log in or register.
Real-World Experience of Upadacitinib Reinduction and High Dose Maintenance Therapy in Inflammatory Bowel Disease
Inflammatory Bowel Disease
Related content
RECOMMENDED
Further Publications
The Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Deza DC, Domínguez CL, Oliver AP, Cuadro CP, Caballero CY, Michelena LA, Esteban AR, Gracia AC, Lidón RV, Roche PC, Usán EC, Sirbu VS, Ruiz CP, López SG
doi: 10.14309/ajg.0000000000003670
Inflammatory Bowel Disease
Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data
BMC Gastroenterol
Dignass A, Teich N, Kaiser S, Sünwoldt J, Dünweber C, Weinhold I, Borchert J, Kudernatsch R
doi: 10.1186/s12876-025-04022-7
RECOMMENDED
Inflammatory Bowel Disease
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Fiorino G, Fidalgo C, Adamina M, Barreiro-de Acosta M, Ali MP, Bortlik M, Burisch J, Dignass A, Drobne D, Faiz O, Ferrante M, Fierens L, Godny L, Gojdicova A, Iacucci M, Jӓghult S, Karmiris K, Kirchgesner J, Restellini S, Rosini F, Shouval D, Yanai H, Zagórowicz E, Walsh A, European Crohn’s Colitis Organisation
doi: 10.1093/ecco-jcc/jjaf105
Inflammatory Bowel Disease
Group-Delivered Mindfulness-Based Cognitive Therapy to Reduce Psychological Distress and Improve Sleep in Patients With Inflammatory Bowel Diseases: A Multicenter Randomized Controlled Trial (MindIBD)
Inflamm Bowel Dis
Ter Avest MM, Huijbers MJ, Horjus CS, Römkens TEH, Witteman EM, van Dop WA, Dresler M, Donders ART, Dijkstra G, Nissen LHC, Speckens AEM
doi: 10.1093/ibd/izaf116
Inflammatory Bowel Disease
Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease
Inflamm Bowel Dis
Dulai PS, Johnson E, Cox K, Eldasher LM, Theriault N
doi: 10.1093/ibd/izae270
Inflammatory Bowel Disease
Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study
Clin Gastroenterol Hepatol
Devi J, Xu A, Stone M, Patel A, Khan A, Reddy N, Klein J, Chowla N, Benson C, Luu BC, Huang K, Jaiprada F, Fenster M, Ungaro R, Pekow J, Johnson AM, Yarur AJ, Shukla R, Huecker J, Bishu S, REBOOT IBD consortium, Deepak P
doi: 10.1016/j.cgh.2025.01.012
Inflammatory Bowel Disease
Histologic and Endoscopic Findings Are Highly Correlated in a Prospective Cohort of Patients With Inflammatory Bowel Diseases
J Crohns Colitis
Di Vincenzo F, Quintero MA, Serigado JM, Koru-Sengul T, Killian RM, Poveda J, England J, Damas O, Kerman D, Deshpande A, Abreu MT
doi: 10.1093/ecco-jcc/jjae141
Inflammatory Bowel Disease
Real-World Experience with Upadacitinib for Pediatric Acute Severe Ulcerative Colitis: An International Multicenter Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN
Inflamm Bowel Dis
Yerushalmy-Feler A, Spencer EA, Bergstein S, Mitrova K, Hradsky O, Bramuzzo M, Wlazlo M, Olbjørn C, Rungoe C, Weil N, Turner D, Cohen S
doi: 10.1093/ibd/izaf166
Inflammatory Bowel Disease
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
Lancet Gastroenterol Hepatol
Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, Hyams J, Weiss B, Aloi M, Assa A, Gerasimidis K, Nichols B, Russell RK, Turner D
doi: 10.1016/S2468-1253(24)00319-4